Levonic (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibiting these targets prevents bacterial DNA synthesis, leading to rapid bactericidal activity against a broad spectrum of Gram‑negative and Gram‑positive organisms.

The specific dose of Levonic is determined by the prescribing clinician based on the infection type, severity, patient weight, renal function, and other clinical factors. No fixed regimen is provided here; the prescriber sets the appropriate dosing schedule.

Safety data for levofloxacin in pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under medical supervision.

To order Levonic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Levonics (levofloxacin) offers once‑daily dosing and a broad spectrum that includes many Gram‑negative and Gram‑positive pathogens, similar to moxifloxacin but with a slightly different activity profile against anaerobes. Choice between agents depends on local resistance patterns, infection site, and patient‑specific factors.

Levonics should be stored at 2–8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain stability and ensure the cold‑chain is maintained during transport and storage.

Levonics is supplied as a sterile injection for intravenous administration. It is typically infused over a prescribed period, often 30–60 minutes, under aseptic conditions by qualified healthcare personnel.

The most serious adverse events include tendon rupture or tendinitis, QT‑interval prolongation leading to arrhythmias, Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, peripheral neuropathy, and hepatic dysfunction. Prompt medical attention is required if any of these occur.

Levonics is contraindicated in patients with known hypersensitivity to levofloxacin or other fluoroquinolones, a history of tendon disorders related to fluoroquinolone use, significant QT prolongation, or those receiving concomitant medications that markedly increase tendon‑rupture risk. Caution is also advised for patients with severe renal impairment.